Literature DB >> 8749315

Regions of the molecule responsible for substrate specificity of monoamine oxidase A and B: a chimeric enzyme analysis.

Y Tsugeno1, I Hirashiki, F Ogata, A Ito.   

Abstract

To examine regions of the monoamine oxidase (MAO, EC 1.4.3.4) molecule responsible for substrate recognition, a series of these enzymes, in which discrete regions in one molecule were substituted by corresponding sequences of the other, were constructed from the cDNAs of rat liver MAO A and MAO B and were expressed in yeast, Saccharomyces cerevisiae. Substrate specificities of the original and chimeric enzymes were examined in terms of the maximum activity (Vmax) and the affinity (Km) for serotonin, beta-phenylethylamine (PEA), and benzylamine. Chimeric enzymes with the amino-terminal portion (about 220 residues) and the amino-terminal and middle portions (about 400 residues) of MAO A and MAO B, respectively, exhibited substantially the same Km values as those of the parent enzymes. Extension of the substitution in the middle portion of a chimeric enzyme to the second half of the amino-terminal portion resulted in conversion of the Km values for serotonin to those of the counterpart. Data on relative Vmax values of the chimeric enzymes for the three substrates revealed that the relative catalytic activities were mainly determined by the presence of the middle portion. We conclude from these observations that the region between about residues 120-220 and about residues 50-400 is responsible for determination of the substrate specificity of MAO A and MAO B, respectively, while the middle portion, of about residues 220-400, may relate to the relative catalytic activity towards substrates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8749315     DOI: 10.1093/jb/118.5.974

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

Review 1.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury.

Authors:  Nina Kaludercic; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Nazareno Paolocci
Journal:  Biochim Biophys Acta       Date:  2010-09-24

2.  Contribution of serotonergic and nitrergic pathways, as well as monoamine oxidase-a and Na+, K+-ATPase enzymes in antidepressant-like action of ((4-tert-butylcyclohexylidene) methyl) (4-methoxystyryl) sulfide (BMMS).

Authors:  Renata L de Oliveira; Guilherme T Voss; Jaini J Paltian; Mikaela P Pinz; Marina Laura C P Torres; Michele P Moreira; Marina C Dilelio; Claudio C Silveira; Ethel A Wilhelm; Cristiane Luchese
Journal:  Metab Brain Dis       Date:  2019-06-08       Impact factor: 3.584

3.  Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling.

Authors:  Rani Maurice Geha; Kevin Chen; Johan Wouters; Frederic Ooms; Jean Chen Shih
Journal:  J Biol Chem       Date:  2002-02-22       Impact factor: 5.157

4.  Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B.

Authors:  Luigi De Colibus; Min Li; Claudia Binda; Ariel Lustig; Dale E Edmondson; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

Review 5.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

6.  Neurochemical binding profiles of novel indole and benzofuran MDMA analogues.

Authors:  Jakob A Shimshoni; Ilan Winkler; Ezekiel Golan; David Nutt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-20       Impact factor: 3.000

7.  Characterization of detergent purified recombinant rat liver monoamine oxidase B expressed in Pichia pastoris.

Authors:  Anup K Upadhyay; Dale E Edmondson
Journal:  Protein Expr Purif       Date:  2008-03-10       Impact factor: 1.650

Review 8.  Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Authors:  Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

9.  Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L.

Authors:  Gemma Margetts; Sotirios Kleidonas; Nawel S Zaibi; Mohamed S Zaibi; Kieron D Edwards
Journal:  BMC Complement Med Ther       Date:  2022-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.